Letter

Authors' reply on aspirin for primary prevention

BMJ 2001; 322 doi: 10.1136/bmj.322.7279.171 (Published 20 January 2001)
Cite this as: BMJ 2001;322:171.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. T W Meade (t.w.meade@mds.qmw.ac.uk), director,
  2. P J Brennan, Statistician
  1. MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London EC1M 6BQ

    EDITOR—By implying disagreements with our study1 which are largely misplaced or non-existent, Ramsay et al may have confused doctors who are deciding about aspirin in the primary prevention of coronary heart disease.2 We pointed out that the British Hypertension Society,3 the hypertension optimal treatment trial,4 and our trial1 all say that aspirin treatment should be started only when blood pressure is satisfactory. Since both aspirin and raised blood pressure are risk factors for …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular